Dr. Marzena Skrzypczak-Zielinska is graduate of biotechnology at the University of Life Sciences in Poznan. After graduating, she was seven months internship within Leonardo da Vinci Programm in the Institute of Human Genetics at the University of Leipzig. Subsequently, she started in Germany at the University of Leipzig the PhD study and after four years she received the Doctor title. Research in this period concern the development of new methods for the detection of dynamic mutations in the neurodegenerative diseases. In January 2009, Dr. Skrzypczak-Zielinska started scientific work at the Institute of Human Genetics Polish Academy of Sciences in the Department of Nucleic Acids Function under supervision of Prof. R. Słomski. Her research interest relate mainly to the molecular aspects determining the occurrence, course and treatment of inflammatory bowel diseases and studies in the field of pharmacogenetics in anesthesia and pain management. Membership in organizations: member of the Polish Society of Human Genetics, of the College of Laboratory Medicine in Poland and of the National Association of Laboratory Diagnosticians.
dr hab. n. med. i n. o zdr. Marzena Skrzypczak-Zielińska
Publications
Alterations in Gut Microbiota Composition in Patients with Covid-19: A pilot Study of whole Hypervariable 16S rRNA Gene Sequencing.
Mańkowska-Wierzbicka D, Żuraszek J, Wierzbicka A, Gabryel M, Mahadea D, Baturo A, Zakerska-Banaszak O, Słomski R, Skrzypczak-Zielińska M, Dobrowolska A
Biomedicines (MDPI), 2023, Jan 27; 11 (2): 367, 16 str; doi: 10.3390/biomedicines11020367IF-4.757 MNiSW-100
Does the VDR gene polymorphism influence the efficacy of denosumab therapy in postmenopausal osteoporosis?
Wawrzyniak A, Skrzypczak-Zielińska M, Michalak M, Kaczmarek-Ryś M, Ratajczak AE, Rychter AM, Skoracka K, Marcinkowska M, Słomski R, Dobrowolska A, Krela-Kaźmierczak I
Front Endocrinol (Lausanne), 2023, Jan 13, 13: 1063762, doi: 10.3389/fendo.2022.1063762.eCollection 2022IF-6.055 MNiSW-100
Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota—A Narrative Review.
Krela-Kaźmierczak I, Zakerska-Banaszak O, Skrzypczak-Zielińska M, Łykowska-Szuber L, Szymczak-Tomczak A, Zawada A, Rychter AM, Ratajczak AE, Skoracka K, Skrzypczak D, Marcinkowska E, Słomski R, Dobrowolska A
Nutrients (MDPI), 2022, 14 (12), 252, 28 str, doi/10.3390/nu14122520IF-5,719 MNiSW-140
Cytotoxicity of thiopurine drugs in patients with inflammatory bowel disease.
Zakerska-Banaszak O, Łykowska-Szuber L, Walczak M, Żuraszek J, Zielińska A, Skrzypczak-Zielińska M
Toxic, 2022, 10 (4), 151, 19 stron, doi/10.3390/toxics1004015IF-4,146 MNiSW-70
Next-generation sequencing analysis in male infertility diagnostics.
Skrzypczak-Zielińska M, Frączek M
Postępy Andrologii online, 2021, 8 (2): 6-15
Myostatin and Follistatin—New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications.
Skrzypczak D, Skrzypczak-Zielińska M, Ratajczak AE, Szymczak-Tomczak A, Eder P, Słomski R, Dobrowolska A, Krela-Kaźmierczak I
Biomedicines (MDPI), 2021, 9 (10), 12 str, 1301. doi.10.3390/biomedicines9101301IF-6,081 MNiSW-20
Vitamin D, Vitamin D Receptor (VDR) Gene Polymorphisms (ApaI and FokI), and Bone Mineral Density in Patients With Inflammatory Bowel Disease.
Szymczak-Tomczak A, Kaczmarek-Ryś M, Hryhorowicz S, Michalak M, Eder P, Skrzypczak-Zielińska M, Łykowska-Szuber L, Tomczak M, Słomski R, Dobrowolska A, Krela-Kaźmierczak I
J Clin Densitometry, 2021 April–June 24 (2): 233-242, Epub 2020 Oct 24, doi: 10.1016/j.jocd.2020.10.009IF-2,310 MNiSW-100
Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease.
Lykowska-Szuber L, Walczak M, Skrzypczak-Zielińska M, Suszynska-Zajczyk J, Stawczyk-Eder K, Waszak K, Eder P, Wozniak A, Krela-Kaźmierczak I, Słomski R and Dobrowolska A
Front Immunol., 2021 09 March, 12, art no 615539, 12 stron, doi: 10. 3389/fimmu.2021.615539IF-5,085 MNiSW-140
NGS study of glucocorticoids response genes in inflammatory bowel disease patients.
Skrzypczak-Zielinska M, Gabryel M, Marszalek D, Dobrowolska A, Slomski R
Arch Med. Sci, 2021, 17 (2): 417-433, Epub 2019 May 5, doi: 10.5114/aoms.2019.84470IF-2,807 MNiSW-70
Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study.
Zakerska-Banaszak O, Tomczak H, Gabryel M, Baturo A, Wolko L, Michalak M, Malinska N, Mankowska-Wierzbicka D, Eder P, Dobrowolska A, Słomski R, Skrzypczak-Zielińska M
Scientific Rep, 2021 Jan 25, 11, art No 2166,.13 str., https://doi.org/10.1038/s41598-021-81628-3IF-3,998 MNiSW-140
All publications
Events
13-16.01.2015 Where:
Krakow, Poland
XXXII Winter School, Pharmacology of cannabinoids
9-10.10.2014 Where:
Poznan, Poland
Scientific Conference, DNA analysis – practice
8 – 11.06.2013 Where:
Paris, France
The European Human Genetics Conference 2013
27-28.11.2012 Where:
Poznan, Poland
Conference Genes and Drugs. I Polish Congress of Pharmacogenetics
23–26.06.2012 Where:
Nürnberg, Germany
The European Human Genetics Conference 2012
12-15.06.2010 Where:
Gothenburg, Sweden
The European Human Genetics Conference 2010
23-26.05.2009 Where:
Vienna, Austria
The European Human Genetics Conference 2009
31.05-03.06.2008 Where:
Barcelona, Spain
The European Human Genetics Conference 2008
16-19.06.2007 Where:
Nice, France
The European Human Genetics Conference 2007
Awards
dr n. roln. Oliwia Zakerska-Banaszak
dr hab. n. med. i n. o zdr. Marzena Skrzypczak-Zielińska
prof. dr hab. n. med. Ryszard Słomski
Biocodex award
Award in the competition 'Microbiota in health and disease' for funding a research project entitled "Treatment of patients with irritable bowel syndrome (IBS) by means of intestinal microbiota transplantation - evaluation of the therapy and its effect on the change of the intestinal microbiome". Manager dr Marcin Gabryel.
